BACKGROUND/AIMS: Fasting plasma glucose (FPG) levels correlate with cardiovascular disease and mortality in both diabetic and non-diabetic subjects. G6PC2 encodes a pancreatic islet-specific glucose-6-phosphatase-related protein and G6pc2-null mice were reported to exhibit decreased blood glucose levels. Two recent genome-wide association studies have implicated a role for G6PC2 in regulation of FPGlevels in the general European population and reported the strongest association with the rs560887 SNP. The purpose of this study was to replicate this association in our independent epidemiological samples. METHODS: DNA samples from non-Hispanic white Americans (NHWs; n = 623), Hispanic Americans (n = 410) and black Africans (n = 787) were genotyped for rs560887 using TaqMan allelic discrimination. RESULTS: While no minor allele A of rs560887 was observed among blacks, its frequency was 33% in NHWs and 17.5% in Hispanics. The rs560887 minor allele was associated with reduced FPG levels in non-diabetic NHWs (p = 0.002 under an additive model). A similar trend of association was observed in non-diabetic Hispanics (p = 0.076 under a dominant model), which was more pronounced in normoglycemic subjects (p = 0.036). CONCLUSIONS: Our results independently confirm the robust association of G6PC2/rs560887 with FPG levels in non-diabetic NHWs. The observed evidence for association in Hispanics warrants further studies in larger samples. 2009 S. Karger AG, Basel.
BACKGROUND/AIMS: Fasting plasma glucose (FPG) levels correlate with cardiovascular disease and mortality in both diabetic and non-diabetic subjects. G6PC2 encodes a pancreatic islet-specific glucose-6-phosphatase-related protein and G6pc2-null mice were reported to exhibit decreased blood glucose levels. Two recent genome-wide association studies have implicated a role for G6PC2 in regulation of FPGlevels in the general European population and reported the strongest association with the rs560887 SNP. The purpose of this study was to replicate this association in our independent epidemiological samples. METHODS: DNA samples from non-Hispanic white Americans (NHWs; n = 623), Hispanic Americans (n = 410) and black Africans (n = 787) were genotyped for rs560887 using TaqMan allelic discrimination. RESULTS: While no minor allele A of rs560887 was observed among blacks, its frequency was 33% in NHWs and 17.5% in Hispanics. The rs560887 minor allele was associated with reduced FPG levels in non-diabetic NHWs (p = 0.002 under an additive model). A similar trend of association was observed in non-diabetic Hispanics (p = 0.076 under a dominant model), which was more pronounced in normoglycemic subjects (p = 0.036). CONCLUSIONS: Our results independently confirm the robust association of G6PC2/rs560887 with FPG levels in non-diabetic NHWs. The observed evidence for association in Hispanics warrants further studies in larger samples. 2009 S. Karger AG, Basel.
Authors: Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: R F Hamman; J A Marshall; J Baxter; L B Kahn; E J Mayer; M Orleans; J R Murphy; D C Lezotte Journal: Am J Epidemiol Date: 1989-02 Impact factor: 4.897
Authors: Leora Henkin; Richard N Bergman; Donald W Bowden; Darrell L Ellsworth; Steven M Haffner; Carl D Langefeld; Braxton D Mitchell; Jill M Norris; Marian Rewers; Mohammed F Saad; Elizabeth Stamm; Lynne E Wagenknecht; Stephen S Rich Journal: Ann Epidemiol Date: 2003-04 Impact factor: 3.797
Authors: C H Bunker; F A Ukoli; F I Okoro; A B Olomu; A M Kriska; S L Huston; N Markovic; L H Kuller Journal: Atherosclerosis Date: 1996-06 Impact factor: 5.162
Authors: Dilek Pirim; Xingbin Wang; Vipavee Niemsiri; Zaheda H Radwan; Clareann H Bunker; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh Journal: Metabolism Date: 2015-09-30 Impact factor: 8.694
Authors: Laura J Rasmussen-Torvik; Xiuqing Guo; Donald W Bowden; Alain G Bertoni; Michele M Sale; Jie Yao; David A Bluemke; Mark O Goodarzi; Y Ida Chen; Dhananjay Vaidya; Leslie J Raffel; George J Papanicolaou; James B Meigs; James S Pankow Journal: Genet Epidemiol Date: 2012-04-16 Impact factor: 2.135
Authors: Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh Journal: J Lipid Res Date: 2013-11-09 Impact factor: 5.922
Authors: Zaheda H Radwan; Xingbin Wang; Fahad Waqar; Dilek Pirim; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; Clareann H Bunker; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh Journal: PLoS One Date: 2014-12-12 Impact factor: 3.240
Authors: Emily K Bryant; Amy S Dressen; Clareann H Bunker; John E Hokanson; Richard F Hamman; M Ilyas Kamboh; F Yesim Demirci Journal: PLoS One Date: 2013-05-22 Impact factor: 3.240